Personal information
Verified email addresses
paul_cavanaugh@mac.com
molecular & biochemical pharmacology, immunopharmacology, global medical & scientific communications, global medical affairs, strategic publication planning, Medical writing, strategic consulting medical communications & medical affairs, Rx, OTC, & consumer product discovery & development, anti-inflammatory agents, anticancer drug discovery, post-surgical local anesthetics, Coxibs and NSAIDs, pain mechanisms and clinical measures, analgesics, topical NSAID products, epinephrine auto-injectors for treatment of anaphylaxis, dental products research & development, periodontal disease research & development, anti-rheumatic drugs and biologics, HPV vaccines, nucleic acids, antisense oligonucleotides, chemical & enzymatic synthesis of modified polynucleotides, translational clinical research, biotechnology, clinical measures validation, biomarkers, skincare cosmetics, general pharmacology, green chemistry
Activities
Employment (14)
2018
to
present
|
Adjunct Professor
(School of Pharmacy and Health Sciences)
Employment
Source:
Paul F. Cavanaugh
2020-03
to
2024-07-15
|
Executive Fellow Global Product Stewardship
(Global Product Safety, Regulatory Affairs & Green Chemistry)
Employment
Source:
Paul F. Cavanaugh
2017-01
to
2020-03
|
Director Scientific Communications
(Medical Sciences)
Employment
Source:
Paul F. Cavanaugh
2017
to
2017
|
Senior Director Medical Publications
(Global Medical Affairs)
Employment
Source:
Paul F. Cavanaugh
2014
to
2017
|
Director Global Publications Sarilumab and Dupilumab
(Global Medical Affairs)
Employment
Source:
Paul F. Cavanaugh
2012
to
2014-10
|
Senior Manager Scientific Communications
(Medical Affairs)
Employment
Source:
Paul F. Cavanaugh
2010
to
2012
|
Director of Publication Planning
Employment
Source:
Paul F. Cavanaugh
2008
to
2010
|
Associate Director Scientific Communications
(Medical Affairs)
Employment
Source:
Paul F. Cavanaugh
2007
to
2008
|
Deputy Director Global Publications Oncology - Nexavar
(U.S. Medical and Scientific Affairs)
Employment
Source:
Paul F. Cavanaugh
2003
to
2007
|
Associate Director Medical Communications
(Clinical Immunology and Analgesia, Clinical and Quantitative Sciences Division )
Employment
Source:
Paul F. Cavanaugh
1992
to
2003
|
Senior Research Scientist
(Oral Care Product Development/New Drug Development)
Employment
Source:
Paul F. Cavanaugh
1993
to
1999
|
Volunteer Associate Professor
(Otolaryngology)
Employment
Source:
Paul F. Cavanaugh
1985
to
1992
|
Senior Scientist Drug Discovery
(Virology and Oncopharmacology)
Employment
Source:
Paul F. Cavanaugh
1982
to
1985
|
Cancer Research Scientist
(Experimental Therapeutics)
Employment
Source:
Paul F. Cavanaugh
Education and qualifications (2)
1977
to
1983
|
PhD
(Biochemical Pharmacology)
Education
Source:
Paul F. Cavanaugh
1973
to
1977
|
BS
(Chemistry)
Education
Source:
Paul F. Cavanaugh
Professional activities (1)
1994
|
Procter and Gamble Health Care Product Development STARRS Award for Excellence in Technology. This award is awarded annually to an individual in Health Care Product Development as the leading research scientist for that year. Recipients are nominated by their scientific peers.
(Healthcare Product Development)
Distinction
Source:
Paul F. Cavanaugh
Funding (1)
1984
to
1984
|
Award
American Cancer Society
(GA, GA, US)
GRANT_NUMBER:
PF-2425
Source:
Paul F. Cavanaugh
Works (50 of 57)
Items per page:
Page 1 of 2
International journal of obstetric anesthesia
2023-02-27
|
Journal article
Contributors:
Ruthi Landau;
Cavanaugh PF;
DiGiorgi M
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Green Chemistry
2021-12-08
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
3)‎
3rd WAO International Scientific Conference, WISC 2014
2015-04-08
|
Conference paper
Source:
Paul F. Cavanaugh
Australasian Society of Clinical Immunology and Allergy (ASCIA) 25th Annual Conference
2014-09
|
Conference paper
Source:
Paul F. Cavanaugh
2014 Annual Meeting of the American Academy of Allergy, Asthma and Immunology, AAAAI 2014
2014-02-28
|
Conference paper
Source:
Paul F. Cavanaugh
2014 Annual Meeting of the American Academy of Allergy, Asthma and Immunology, AAAAI 2014
2014-02-28
|
Conference paper
Source:
Paul F. Cavanaugh
The Journal of allergy and clinical immunology
2013-05-29
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Therapeutics and clinical risk management
2012-01-25
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Therapeutics and clinical risk management
2012-01-25
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
The 51st Annual National Institute of Mental Health (NIMH) New Clinical Drug Evaluation Unit (NCDEU) Meeting, Boca Raton, Florida, June 13–16, 2011Posters Most Relevant to Child and Adolescent Psychopharmacology
2011-12-13
|
Conference paper
Source:
Paul F. Cavanaugh
Journal of clinical pharmacology
2009-10-01
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Journal of clinical pharmacology
2008-04-23
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Journal of clinical pharmacology
2007-07-26
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Journal of Rheumatology
2006
|
Journal article
EID:
2-s2.0-33646450531
Contributors:
Reiff, A.;
Lovell, D.J.;
Van Adelsberg, J.;
Kiss, M.H.B.;
Goodman, S.;
Zavaler, M.F.;
Chen, P.-Y.;
Bolognese, J.A.;
Cavanaugh Jr., P.F.;
Reicin, A.S.
et al.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
Current medical research and opinion
2006-12-01
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Regional anesthesia and pain medicine
2006-03-01
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Annals of the rheumatic diseases
2005-02-24
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Drugs of Today
2004
|
Journal article
EID:
2-s2.0-3042780168
Contributors:
Matsumoto, A.K.;
Cavanaugh Jr., P.F.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
Clinical Cancer Research : an official journal of the American Association for Cancer Research
2004-03-01
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
2003-07-03
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Journal of the American Dental Association (1939)
2003-07-01
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2000-08-01
|
Journal article
Source:
Paul F. Cavanaugh
Journal of Periodontal Research
1998
|
Journal article
EID:
2-s2.0-0031995419
Contributors:
Cavanaugh Jr., P.F.;
Meredith, M.P.;
Buchanan, W.;
Doyle, M.J.;
Reddy, M.S.;
Jeffcoat, M.K.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
In: Rainsford K.D. (eds) Side Effects of Anti-Inflammatory Drugs IV. Springer, Dordrecht
1997
|
Book chapter
Source:
Paul F. Cavanaugh
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Source:
Paul F. Cavanaugh
Research Communications in Molecular Pathology and Pharmacology
1996
|
Journal article
EID:
2-s2.0-0029983043
Contributors:
Cavanaugh Jr., P.F.;
Ho, Y.-K.;
Bardos, T.J.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Journal of periodontal research
1996-04-01
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Research communications in molecular pathology and pharmacology
1996-02-01
|
Journal article
Source:
Paul F. Cavanaugh
Inflammopharmacology
1995
|
Journal article
EID:
2-s2.0-0029008958
Contributors:
Cavanaugh, P.F.;
Mcdonald, J.S.;
Pavelic, L.;
Limardi, R.J.;
Gluckman, J.L.;
Pavelic, Z.P.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
Inflammopharmacology
1995
|
Journal article
EID:
2-s2.0-0029568025
Contributors:
Cavanaugh, P.F.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
1995-03-13
|
Patent
PAT:
US5626838A
Source:
Paul F. Cavanaugh
The Journal of Organic Chemistry
1993-12
|
Journal article
Source:
Paul F. Cavanaugh
grade
Preferred source
(of
2)‎
Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development
1992
|
Book chapter
Source:
Paul F. Cavanaugh
Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development
1992
|
Book chapter
Source:
Paul F. Cavanaugh
Investigational New Drugs
1990
|
Journal article
EID:
2-s2.0-0025085950
Contributors:
Cavanaugh Jr., P.F.;
Moskwa, P.S.;
Donish, W.H.;
Pera, P.J.;
Richardson, D.;
Andrese, A.P.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
1990-08-03
|
Patent
PAT:
US5245022A
Source:
Paul F. Cavanaugh
1990-08-03
|
Patent
PAT:
US5567810A
Source:
Paul F. Cavanaugh
1990-08-03
|
Patent
PAT:
US5677439A
Source:
Paul F. Cavanaugh
Proc. Am. Assoc. Cancer Res. 1989
1989
|
Conference abstract
Contributors:
Paul F. Cavanaugh;
William Pilgermayer
Source:
Paul F. Cavanaugh
Source:
Paul F. Cavanaugh
Proceedings of the American Association for Cancer Research
1985
|
Journal article
EID:
2-s2.0-17344381234
Contributors:
Cavanaugh Jr., P.F.;
McManis, J.S.;
Frankfurt, O.S.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
Cancer Research
1985
|
Journal article
EID:
2-s2.0-0021893570
Contributors:
Porter, C.W.;
Cavanaugh, P.F.;
Ganis, B.;
Kelly, E.;
Bergeron, R.J.;
Stolowich, N.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
Cancer Research
1985
|
Journal article
EID:
2-s2.0-0022357907
Contributors:
Cavanaugh, P.F.;
Porter, C.W.;
Frankfurt, O.S.;
Pavelic, Z.P.;
Bergeron, R.J.;
Tukalo, D.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
Proceedings of the American Association for Cancer Research
1985
|
Journal article
EID:
2-s2.0-17344378605
Contributors:
Porter, C.W.;
Cavanaugh Jr., P.F.;
Bergeron, R.J.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
Proceedings of the American Association for Cancer Research
1985
|
Journal article
EID:
2-s2.0-17144465981
Contributors:
Cavanaugh Jr., P.F.;
Bergeron, R.J.;
Porter, C.W.
Source:
Paul F. Cavanaugh
via
Scopus - Elsevier
Source:
Paul F. Cavanaugh
Items per page:
Page 1 of 2